Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma

Supplementary Video S2B from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma

<p>40 min full dynamic Total-body PET imaging of Patient 8</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Xiaojiang Duan (15439264) (author)
Autres auteurs:	Lei Xia (15439267) (author), Zhuochen Zhang (15439270) (author), Yanan Ren (15439273) (author), Martin G. Pomper (10938220) (author), Steven P. Rowe (10938217) (author), Xuesong Li (15439276) (author), Nan Li (15276704) (author), Ning Zhang (15439279) (author), Hua Zhu (15439282) (author), Zhi Yang (15439285) (author), Xinan Sheng (15030377) (author), Xing Yang (15439288) (author)
Publié:	2025
Sujets:	Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Methods and Technology Biomarkers Imaging biomarkers Clinical Imaging Genitourinary Cancers Bladder cancer Imaging Imaging probes Positron emission tomography (PET) Translational Research
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Supplementary Video S1 from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
par: Xiaojiang Duan (15439264)
Publié: (2025)

Supplementary Video S2A from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
par: Xiaojiang Duan (15439264)
Publié: (2025)

Supplementary Video S2C from First-in-Human Study of the Radioligand <sup>68</sup>Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
par: Xiaojiang Duan (15439264)
Publié: (2025)

Figure 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
par: Friederike Hesse (14958870)
Publié: (2025)

Figure 2 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
par: Friederike Hesse (14958870)
Publié: (2025)

Figure 3 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
par: Friederike Hesse (14958870)
Publié: (2025)

Figure 4 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
par: Friederike Hesse (14958870)
Publié: (2025)

Figure 5 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
par: Friederike Hesse (14958870)
Publié: (2025)

Figure 6 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
par: Friederike Hesse (14958870)
Publié: (2025)

Figure 7 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
par: Friederike Hesse (14958870)
Publié: (2025)

Table 1 from Imaging Glioblastoma Response to Radiotherapy Using <sup>2</sup>H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism
par: Friederike Hesse (14958870)
Publié: (2025)

Figure 1 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
par: Vinton W.T. Cheng (15020397)
Publié: (2025)

Figure 2 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
par: Vinton W.T. Cheng (15020397)
Publié: (2025)

Figure 3 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
par: Vinton W.T. Cheng (15020397)
Publié: (2025)

Figure 4 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
par: Vinton W.T. Cheng (15020397)
Publié: (2025)

Figure 5 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
par: Vinton W.T. Cheng (15020397)
Publié: (2025)

Figure 6 from VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
par: Vinton W.T. Cheng (15020397)
Publié: (2025)

Supplementary Video from Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
par: Laura Privitera (16015972)
Publié: (2025)

Data Sheet 1_Intra-voxel incoherent motion biomarker repeatability in healthy volunteers and sensitivity to chemoradiotherapy-induced changes in patients with uterine cervical cancer.pdf
par: Damien J. McHugh (22686269)
Publié: (2025)

Figure 1 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
par: Isabel Quiros-Gonzalez (14952835)
Publié: (2025)

Figure 2 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
par: Isabel Quiros-Gonzalez (14952835)
Publié: (2025)

Figure 3 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
par: Isabel Quiros-Gonzalez (14952835)
Publié: (2025)

Figure 4 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
par: Isabel Quiros-Gonzalez (14952835)
Publié: (2025)

Figure 5 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
par: Isabel Quiros-Gonzalez (14952835)
Publié: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
par: Matthia A. Karreman (15097355)
Publié: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
par: Matthia A. Karreman (15097355)
Publié: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
par: Matthia A. Karreman (15097355)
Publié: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
par: Matthia A. Karreman (15097355)
Publié: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
par: Matthia A. Karreman (15097355)
Publié: (2025)

Supplementary Data from Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
par: Matthia A. Karreman (15097355)
Publié: (2025)

Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
par: Michelle L. Mierzwa (14963463)
Publié: (2025)

Textural changes are more sensitive than volumetry of amygdala in cocaine use disorder patients: potential for low field translation
par: Shounak Nandi (22675916)
Publié: (2025)

Table S1 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
par: Noor Jailkhani (16015810)
Publié: (2025)

Table S2 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
par: Noor Jailkhani (16015810)
Publié: (2025)

Table S3 from Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and Metastases
par: Noor Jailkhani (16015810)
Publié: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
par: Shasha Wei (1555588)
Publié: (2025)

FigureS1 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
par: Jonathan Chou (14957015)
Publié: (2025)

FigureS10 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
par: Jonathan Chou (14957015)
Publié: (2025)

FigureS2 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
par: Jonathan Chou (14957015)
Publié: (2025)

FigureS3 from Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer
par: Jonathan Chou (14957015)
Publié: (2025)

Cannot write session to /tmp/vufind_sessions/sess_vfmn1srno77c8p3ckmgrr4ev11